N-MYC amplification is associated with which tumor?
**Core Concept**
N-MYC amplification is a genetic abnormality characterized by the overexpression of the N-MYC oncogene, which is a member of the MYC family of transcription factors. This amplification is often found in certain types of tumors and is associated with aggressive clinical behavior.
**Why the Correct Answer is Right**
N-MYC amplification is predominantly associated with neuroblastoma, a type of pediatric cancer that arises from the sympathetic nervous system. The amplification of N-MYC leads to increased transcriptional activity, resulting in enhanced cell proliferation, survival, and resistance to apoptosis. This contributes to the aggressive growth and poor prognosis of neuroblastoma.
**Why Each Wrong Option is Incorrect**
**Option A:** N-MYC amplification is not typically associated with Wilms tumor, a type of kidney cancer that affects children. While genetic abnormalities are common in Wilms tumor, N-MYC amplification is not a characteristic feature.
**Option B:** N-MYC amplification is not a hallmark of retinoblastoma, a malignant tumor of the retina. The genetic mutations associated with retinoblastoma, such as RB1 gene mutations, are distinct from N-MYC amplification.
**Option C:** N-MYC amplification is not a common feature of medulloblastoma, a type of brain cancer that affects children. While genetic abnormalities are present in medulloblastoma, N-MYC amplification is not a characteristic feature.
**Clinical Pearl / High-Yield Fact**
Neuroblastoma is a highly heterogeneous disease, and N-MYC amplification is one of the key molecular markers used to predict prognosis and guide treatment decisions. Patients with N-MYC amplified neuroblastoma tend to have a poorer prognosis and may require more aggressive treatment approaches.
**Correct Answer:** A. Neuroblastoma